clinical trials

News

Has trial result burst BMS' Cobenfy bubble?

Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a failed clinical trial.

News

Data readout puts J&J's bladder cancer drug back on track

New data in non-muscle-invasive bladder cancer (NMIBC) has backed up Johnson & Johnson's faith in its TAR-200 drug candidate.

News

Sky Labs' smart ring tops Apple Watch in AFib comparison

A smart ring developed by South Korean healthtech Sky Labs has outperformed the Apple Watch in a head-to-head comparison.

News

Woman with breast cancer covering her chest with her hands

Enhertu poised to move first line in HER2+ breast cancer

New data could make HER2-directed antibody-drug conjugate (ADC) Enhertu an option for previously untreated breast cancer for the first time.

News

Vials on a conveyor belt - pharma manufacturing

Trodelvy-Keytruda pairing hits the spot in breast cancer

Gilead Sciences has cemented the role of its TROP2 drug Trodelvy in triple-negative breast cancer with a study win in combination with MSD's Keytruda.

News

Lilly soars on first data for oral obesity candidate

Shares in Eli Lilly rose sharply in pre-market trading today after it reported phase 3 results for oral diabetes and weight-loss drug orforglipron.

Has trial result burst BMS' Cobenfy bubble?

Data readout puts J&J's bladder cancer drug back on track

Sky Labs' smart ring tops Apple Watch in AFib comparison

Enhertu poised to move first line in HER2+ breast cancer

Trodelvy-Keytruda pairing hits the spot in breast cancer

Lilly soars on first data for oral obesity candidate

Argenx pens $2.2bn deal to buy autoimmune biotech Forte

Discover a new era of healthcare panel engagement: Grounded ...

clinical trials

Editor's Picks